Meeting
2017 Gastrointestinal Cancers Symposium
Trastuzumab beyond progression in patients with HER2 positive advanced gastric adenocarcinoma: A multicenter AGEO study.
Authors
Juliette Palle
Hopital Europeen Georges Pompidou, Paris, France
Juliette Palle , David Tougeron , Astrid Pozet , Emilie Soularue , Pascal Artru , Florence Le Roy , Olivier Dubreuil , Matthieu Sarabi , Nicolas Williet , Sylvain Manfredi , Jerome Martin-Babau , Christine Rebischung , Meher Ben Abdelghani , Ludovic Evesque , Johann Dreanic , Vincent Hautefeuille , Christophe Louvet , Thierry Lecomte , Julien Taïeb , Aziz Zaanan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 94)
DOI
10.1200/JCO.2017.35.4_suppl.94
Abstract #
94
Poster Bd #
H6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results.
First Author: Yelena Y. Janjigian
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.
First Author: Ali Fawaz
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Post-recurrent survival of a phase III trial comparing adjuvant chemotherapy with docetaxel plus S-1 versus S-1 alone in stage III gastric cancer: A post-hoc analysis of the START-2 trial (JACCRO GC-07).
First Author: Hiroo Ishida
Poster
2020 ASCO Virtual Scientific Program
Final results of a phase II trial of first-line FOLFIRINOX for advanced gastroesophageal cancers.
First Author: Ramon Jin